<DOC>
	<DOCNO>NCT01233739</DOCNO>
	<brief_summary>Patients present rhizarthrosis diagnostic randomize treated chondroitin sulfate placebo 24 week study effect treatment objective subjective indicator pain sensibility .</brief_summary>
	<brief_title>Chondroitin Sulphate Treatment Efficacy Rhizarthrosis .</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>sex patient age 45 75 year mechanical pain trapeziumthumb metacarpal joint 3 month duration grade II III Eaton &amp; Glickel rhizarthrosis radiological diagnose pain inclusion &gt; = 40 mm visual analogue scale without rehabilitation treatment infiltration last 6 month accept participate sign inform consent patient rhizarthrosis result rheumatic disease patient joint surgery traumatic background illiterate patient unable understand inform consent patient previous neuropsychopathology enough severe unable participation study patient peripheral sensory impairment due diabetes , peripheral neuropathy central neurological sequela disease affect limb alter sensory perception patient coagulopathy inflammation process joint study treatment nonsteroidal antiinflammatory drug last 7 day and/or corticosteroid last 30 day allergy hypersensibility chondroitin sulfate excipients pregnant breastfeed woman</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>rhizarthrosis</keyword>
	<keyword>Chondroitin sulfate</keyword>
	<keyword>Placebo</keyword>
</DOC>